Phase angle assessed by bioelectrical impedance analysis in patients with colorectal cancer: a systematic review
- 1Department of General Surgery, Yuncheng Tongde Hospital , , ,
- 2Department of General Surgery, Third Hospital of Shanxi Medical University, Shanxi Bethune Hospital, Shanxi Academy of Medical Sciences, Tongji Shanxi Hospital , ,
Abstract
Background: Malnutrition, altered body composition, and sarcopenia are common among patients with colorectal cancer (CRC) and are associated with poor treatment tolerance and adverse clinical outcomes. PhA, derived from BIA, reflects cellular membrane integrity and body cell mass and has been increasingly investigated as a potential marker of nutritional status and prognosis in oncology. However, the clinical relevance of PhA in patients with CRC has not yet been systematically synthesized.
Methods: This systematic review was conducted in accordance with the PRISMA 2020 guidelines. PubMed, Embase, Web of Science, and Scopus were searched for observational studies published between January 2000 and October 2025 that assessed PhA in adult patients with CRC. Data extraction and risk-of-bias assessment using the AXIS tool were performed independently by two reviewers. Due to substantial heterogeneity in study design, outcome definitions, and PhA cut-off values, a narrative synthesis was conducted.
Results: A total of 10 studies involving 1,439 patients were included. Lower PhA values were consistently associated with adverse clinical outcomes. Four studies reported significantly shorter overall or progression-free survival among patients with low PhA. Four studies demonstrated associations between low PhA and unfavorable short-term outcomes, including postoperative complications, prolonged hospital stay, cancer-related complications, and early chemotherapy-related toxicity. Several studies also reported positive associations between PhA and indicators of nutritional status, body composition, muscle mass, muscle strength, and hydration balance. One longitudinal study showed that postoperative increases in PhA were accompanied by improvements in body composition parameters and reduced early chemotherapy-related toxicity.
Conclusions: Current evidence indicates that BIA-derived phase angle is associated with nutritional status, body composition, treatment tolerance, and survival outcomes in patients with colorectal cancer. However, heterogeneity in measurement protocols and cut-off values limits direct clinical application. Standardized assessment methods and prospective studies are needed to establish CRC-specific reference values and to determine whether interventions that improve PhA can translate into improved clinical outcomes.
Related
- Missing Link between Glycemic Control and Bioelectrical Impedance Analysis
- Bioelectrical impedance-derived body composition and systemic therapy outcomes in non-small cell lung cancer
- Toward Clinically Feasible Assessment of Muscle Mass: Validation of a Seated Bioelectrical Impedance Device Against Dual-Energy X-Ray Absorptiometry (DXA) in Older Adults
- Association of electrical properties of bioelectrical impedance spectroscopy with sedentary time, physical activity and muscle function in older adults
- Trimester-Specific Bioelectrical Impedance Reference Curves in Physiological Pregnancy: Mapping Maternal Body Composition and Hydration Trajectories
BibTeX
@article{mei2026phase,
title = {{Phase angle assessed by bioelectrical impedance analysis in patients with colorectal cancer: a systematic review}},
author = {Yuzhou Mei and Tengfei Wang and Songhao Liu and Haoyu Wang and Zhenguo Han},
journal = {Frontiers in oncology},
year = {2026},
month = sep,
doi = {10.3389/fonc.2026.1768933},
url = {https://europepmc.org/article/PMC/PMC13661394},
note = {CC BY},
}
RIS
TY - JOUR
TI - Phase angle assessed by bioelectrical impedance analysis in patients with colorectal cancer: a systematic review
AU - Yuzhou Mei
AU - Tengfei Wang
AU - Songhao Liu
AU - Haoyu Wang
AU - Zhenguo Han
PY - 2026
DA - 2026/09/30
JO - Frontiers in oncology
DO - 10.3389/fonc.2026.1768933
UR - https://europepmc.org/article/PMC/PMC13661394
AB - Background: Malnutrition, altered body composition, and sarcopenia are common among patients with colorectal cancer (CRC) and are associated with poor treatment tolerance and adverse clinical outcomes. PhA, derived from BIA, reflects cellular membrane integrity and body cell mass and has been increasingly investigated as a potential marker of nutritional status and prognosis in oncology. However, the clinical relevance of PhA in patients with CRC has not yet been systematically synthesized. Methods: This systematic review was conducted in accordance with the PRISMA 2020 guidelines. PubMed, Embase, Web of Science, and Scopus were searched for observational studies published between January 2000 and October 2025 that assessed PhA in adult patients with CRC. Data extraction and risk-of-bias assessment using the AXIS tool were performed independently by two reviewers. Due to substantial heterogeneity in study design, outcome definitions, and PhA cut-off values, a narrative synthesis was conducted. Results: A total of 10 studies involving 1,439 patients were included. Lower PhA values were consistently associated with adverse clinical outcomes. Four studies reported significantly shorter overall or progression-free survival among patients with low PhA. Four studies demonstrated associations between low PhA and unfavorable short-term outcomes, including postoperative complications, prolonged hospital stay, cancer-related complications, and early chemotherapy-related toxicity. Several studies also reported positive associations between PhA and indicators of nutritional status, body composition, muscle mass, muscle strength, and hydration balance. One longitudinal study showed that postoperative increases in PhA were accompanied by improvements in body composition parameters and reduced early chemotherapy-related toxicity. Conclusions: Current evidence indicates that BIA-derived phase angle is associated with nutritional status, body composition, treatment tolerance, and survival outcomes in patients with colorectal cancer. However, heterogeneity in measurement protocols and cut-off values limits direct clinical application. Standardized assessment methods and prospective studies are needed to establish CRC-specific reference values and to determine whether interventions that improve PhA can translate into improved clinical outcomes.
SN - 2234-943X
ER -